Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine

Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine

(2017) Michael Theisen et al.   Expert Review of Vaccines

A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

(2016) Sodiomon B. Sirima et al.   VACCINE

Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen

(2016) Susan L. Baldwin et al.   VACCINE

Bacterial superglue enables easy development of efficient virus-like particle based vaccines

(2016) Susan Thrane et al.   JOURNAL OF NANOBIOTECHNOLOGY

Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45

(2016) Michael Pritsch et al.   Journal of Immunology Research

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization

(2016) Karl D. Brune et al.   Scientific Reports

Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants

(2015) Will Roeffen et al.   MALARIA JOURNAL

A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies

(2015) Susheel K. Singh et al.   VACCINE

Development of a Single-Replicon miniBYV Vector for Co-expression of Heterologous Proteins

(2014) Alex Prokhnevsky et al.   MOLECULAR BIOTECHNOLOGY

Superglue from bacteria: unbreakable bridges for protein nanotechnology

(2014) Gianluca Veggiani et al.   TRENDS IN BIOTECHNOLOGY

A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages

(2014) Michael Theisen et al.   VACCINE

Recombinant protein expression inLactococcus lactisusing the P170 expression system

(2013) Casper M. Jørgensen et al.   FEMS MICROBIOLOGY LETTERS

Engineering Signal Peptides for Enhanced Protein Secretion from Lactococcus lactis

(2012) Daphne T. W. Ng et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii

(2012) Carla S. Jones et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Measuring the blockade of malaria transmission – An analysis of the Standard Membrane Feeding Assay

(2012) Thomas S. Churcher et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children

(2011) Sabine Bélard et al.   PLoS One

A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate

(2011) Susana Lousada-Dietrich et al.   VACCINE

A Research Agenda to Underpin Malaria Eradication

(2011) Pedro L. Alonso et al.   PLOS MEDICINE

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon

(2010) Benjamin Mordmüller et al.   VACCINE

Disulfide Bond Formation and Cysteine Exclusion in Gram-positive Bacteria

(2009) Robert Daniels et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Safety and immunogenicity of GMZ2 — a MSP3–GLURP fusion protein malaria vaccine candidate

(2009) Meral Esen et al.   VACCINE